Reaction
Periostitis reporting signals
As of the last recalculation, Periostitis appears in 432 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is VORICONAZOLE INJECTION (PRR 1,050.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Voriconazole Injection | 226 | 1,050.5 | 1,061.6 |
| Voriconazole | 236 | 823.8 | 830.3 |
| Micafungin Sodium | 19 | 112.9 | 113.1 |
| Amphotericin B | 16 | 63.9 | 63.9 |
| Basiliximab | 15 | 63.6 | 63.7 |
| Terbinafine Hydrochloride | 11 | 61.2 | 61.3 |
| Moxifloxacin | 14 | 49.5 | 49.5 |
| Baricitinib | 8 | 40.7 | 40.7 |
| Mycophenilic Acid | 16 | 38.6 | 38.6 |
| Valganciclovir Hydrochloride Powder, | 9 | 36.3 | 36.3 |
| Tacrolimus Ointment 0.1% | 74 | 34.3 | 34.4 |
| Tacrolimus Extended-Release Capsules | 74 | 34.2 | 34.3 |
| Remdesivir | 6 | 22.0 | 22.0 |